Genomics as a probe for disease biologyBURKE, Wylie.The New England journal of medicine. 2003, Vol 349, Num 10, pp 969-974, issn 0028-4793, 6 p.Article

Screening an Asymptomatic Person for Genetic RiskBURKE, Wylie; DIMMOCK, David.The New England journal of medicine. 2014, Vol 370, Num 25, pp 2442-2445, issn 0028-4793, 4 p.Article

Ensuring the appropriate use of genetic testsBURKE, Wylie; ZIMMERN, Ron L.Nature reviews. Genetics (Print). 2004, Vol 5, Num 12, pp 955-959, issn 1471-0056, 5 p.Article

The complexities of predictive genetic testingEVANS, James P; SKRZYNIA, Cécile; BURKE, Wylie et al.BMJ. British medical journal (International ed.). 2001, Vol 322, Num 7293, pp 1052-1056, issn 0959-8146Article

Genomic profiling to promote a healthy lifestyle: not ready for prime timeHAGA, Susanne B; KHOURY, Muin J; BURKE, Wylie et al.Nature genetics. 2003, Vol 34, Num 4, pp 347-350, issn 1061-4036, 4 p.Article

Adding pharmacogenetics information to drug labels: lessons learnedHAGA, Susanne B; THUMMEL, Kenneth E; BURKE, Wylie et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 12, pp 847-854, issn 1744-6872, 8 p.Article

Changing the clinical management of hereditary hemochromatosis: Translating screening and early case detection strategies into clinical practiceHOVER, Alexander R; MCDONNELL, Sharon M; BURKE, Wylie et al.Archives of internal medicine (1960). 2004, Vol 164, Num 9, pp 957-961, issn 0003-9926, 5 p.Article

Hereditary haemochromatosis: a realistic approach to prevention of iron overload disease in the populationBURKE, Wylie; REYES, Michele; IMPERATORE, Giuseppina et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 2, pp 315-328, issn 1521-6926, 14 p.Article

Genetic ScreeningBURKE, Wylie; TARINI, Beth; PRESS, Nancy A et al.Epidemiologic reviews. 2011, Vol 33, pp 148-164, issn 0193-936X, 17 p.Article

Are Doctors Prepared for Direct-to-Consumer Advertising of Genetics Tests? CommentaryTRACY, Erin E; HUDSON, Kathy; JAVITT, Gail et al.Obstetrics and gynecology (New York. 1953). 2007, Vol 110, Num 6, pp 1389-1395, issn 0029-7844, 7 p.Article

Risk, Reward, and the Double-Edged Sword: Perspectives on Pharmacogenetic Research and Clinical Testing Among Alaska Native PeopleSHAW, Jennifer L; ROBINSON, Renee; STARKS, Helene et al.American journal of public health (1971). 2013, Vol 103, Num 12, pp 2220-2225, issn 0090-0036, 6 p.Article

Population description and its role in the interpretation of genetic associationFULLERTON, Stephanie M; YU, Joon-Ho; CROUCH, Julia et al.Human genetics. 2010, Vol 127, Num 5, pp 563-572, issn 0340-6717, 10 p.Article

Categorizing genetic tests to identify their ethical, legal, and social implicationsBURKE, Wylie; PINSKY, Linda E; PRESS, Nancy A et al.American journal of medical genetics. 2001, Vol 106, Num 3, pp 233-240, issn 0148-7299Article

Waiving Informed Consent in Newborn Screening Research : Balancing Social Value and RespectTARINI, Beth A; BURKE, Wylie; SCOTT, C. Ronald et al.American journal of medical genetics. Part C, Seminars in medical genetics. 2008, Vol 148, Num 1, pp 23-30, issn 1552-4868, 8 p.Article

'that's like chopping off a finger because you're afraid it might get broken' : Disease and illness in women's views of prophylactic mastectomyPRESS, Nancy; REYNOLDS, Susan; PINSKY, Linda et al.Social science & medicine (1982). 2005, Vol 61, Num 5, pp 1106-1117, issn 0277-9536, 12 p.Article

Family history assessment to detect increased risk for colorectal cancer : Conceptual considerations and a preliminary economic analysisRAMSEY, Scott D; BURKE, Wylie; PINSKY, Linda et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 11, pp 2494-2500, issn 1055-9965, 7 p., 1Article

Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectationsPRESS, Nancy A; YASUI, Yutaka; REYNOLDS, Susan et al.American journal of medical genetics. 2001, Vol 99, Num 2, pp 99-110, issn 0148-7299Article

Pharmacogenetic study of statin therapy and cholesterol reduction. CommentaryCHASMAN, Daniel I; POSADA, David; SUBRAHMANYAN, Lakshman et al.JAMA, the journal of the American Medical Association. 2004, Vol 291, Num 23, pp 2821-2827, issn 0098-7484, 10 p.Article

Informed consent for population-based research involving geneticsBESKOW, Laura M; BURKE, Wylie; MERZ, Jon F et al.JAMA, the journal of the American Medical Association. 2001, Vol 286, Num 18, pp 2315-2321, issn 0098-7484Article

Genetic Assessment of Breast Cancer Risk in Primary Care PracticeBURKE, Wylie; CULVER, Julie; PINSKY, Linda et al.American journal of medical genetics. Part A. 2009, Vol 149, Num 3, pp 349-356, issn 1552-4825, 8 p.Article

Comparisons of two breast cancer risk estimates in women with a family history of breast cancerMCTIERNAN, Anne; KUNIYUKI, Alan; YASUI, Yutaka et al.Cancer epidemiology, biomarkers & prevention. 2001, Vol 10, Num 4, pp 333-338, issn 1055-9965Article

Motivating Factors for Physician Ordering of Factor V Leiden Genetic TestsHINDORFF, Lucia A; BURKE, Wylie; LABERGE, Anne-Marie et al.Archives of internal medicine (1960). 2009, Vol 169, Num 1, pp 68-74, issn 0003-9926, 7 p.Article

National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate CancerGANZ, Patricia A; BARRY, John M; SEIFTER, Eric J et al.Annals of internal medicine. 2012, Vol 156, Num 8, pp 591-595, issn 0003-4819, 5 p.Article

Ethical issues in identifying and recruiting participants for familial genetic researchBESKOW, Laura M; BOTKIN, Jeffrey R; SUSSWEIN, Lisa R et al.American journal of medical genetics. 2004, Vol 130A, Num 4, pp 424-431, issn 0148-7299, 8 p.Article

Page / 2